London-Routine testing for color vision deficiency is not a reliable method to detect digoxin toxicity in patients taking the drug for heart failure or other cardiac problems, said J.G. Lawrenson, PhD.
J.G. Lawrenson, PhD
Advertisement
Dr. Lawrenson, who is a professor of optometry, Applied Vision Research Centre, Department of Optometry and Visual Science, City University, London.
Articles by J.G. Lawrenson, PhD
Advertisement
Latest Updated Articles
- Patients taking digoxin may develop color blindness
Published: May 1st 2003 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA clears BVI’s FineVision HP trifocal IOL for the US market
2
AAO 2025: A practice’s experience with connecting "the why," building community for techs
3
Ophthalmology over the decades: A catalyst of innovation in the 1970s
4
Ophthalmic innovation by the decades: The 1980s and 1990s
5
.png "Optometry Times"){kind=logo}
